ArticleBMC dermatology2012
A phase I study of daily treatment with a ceramide-dominant triple lipid mixture commencing in neonates.
Adrian J Lowe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it